NewsRoom Articles - Page 134 of 202

MondayAug 16, 2021 12:04 pm

DGE’s Blockchain Pharma & Life Sciences Summit To Bring Together Industry Leaders For A Consolidated Global Blockchain Management System

Medical professionals are invited to attend DGE’s Blockchain Pharma & Life Sciences Summit on August 23-24, 2021 to learn successful strategies of successfully using the decentralized technology to boost trust and improve transparency throughout the life science ecosystem including regulators, contract manufacturers, physicians, and patients. The event is hosted by Dynamic Global Events (“DGE”), a life science leader in organizing b2b events. The world-class event company is an industry leader meeting the dynamic informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries. Attendees will discover the various areas that blockchain technology can be used in including clinical research…

FridayAug 13, 2021 2:36 pm

Rare Cannabinoids Slowly Revolutionizing the Pharmaceutical Industry

Cannabis is now legal for recreational use in 18 states and legal for medicinal use in 36 states across the country. As the plant gains more popularity, so do some of its products, the most popular ones being THC and CBD, which are cannabinoids. Cannabinoids are compounds found in the cannabis plant. Other cannabinoids found in the cannabis plant include tetrahydrocannabivarin (“THCV”), cannabinol (“CBN”) and cannabigerol (“CBG”), among others. These rare cannabinoids don’t possess THC’s psychoactive properties and have been found to be more potent in comparison to CBD. Forecasts show that by the year 2029, the international market for…

FridayAug 13, 2021 9:00 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Bolsters its Advisory Board With The Appointment of Jerry White

Mind Cure Health Inc. announced Jerry White’s appointment into the company’s advisory board Mr. White brings a wealth of experience from his years of powering global movements and working with key leaders and personalities around the world MINDCURE forecasts that with Mr. White’s addition to the board, the company will be well-positioned to achieve bigger and better goals, all while working towards its overall vision of building mental wealth globally Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) announced that it has appointed Jerry White as an advisor to the company. Mr. White would be an excellent addition to…

FridayAug 13, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) CEO Shares Insights on the Psychedelics Space on The Dealmaker Podcast

Mr. Greg McKee, CEO of Tryp Therapeutics, appeared on The Dealmaker Podcast to share insights on the company and the psychedelics industry During the interview, he discussed the potential of psychedelics in the treatment of PTSD and other mental disorders Greg also shared the challenges that the industry is facing currently, mostly to do with legislation McKee also shared how people can help the company and the industry by pushing for the decriminalization of psychedelics and taking part in clinical trials On August 2, 2021, the Dealmaker Podcast posted an interview with Greg McKee, the Chief Executive Officer (“CEO”) of…

ThursdayAug 12, 2021 11:33 am

Anpac Bio Continues Growth Trajectory

In recent years, advances in technology have led to demand for early cancer testing and screening methods that are less invasive and lower cost. Insurance companies have accepted that traditional testing methods are labor intensive and are not ideal as the first line of defense when screening and diagnosing cancer. This has opened a multi-billion-dollar market opportunity in discovering new solutions to tackle cancer and disease testing outside of traditional diagnostics that have been used for generations without any major upgrades or breakthroughs. AnPac Bio-Medical Science Co., Ltd. (ANPC.US), a biotechnology company focused on early cancer screening and detection as…

ThursdayAug 12, 2021 10:48 am

Fluorescent Imaging Agent May Allow for Better Cervical Cancer Detection

Recently conducted research has discovered that cervical cancer can be detected by clinicians using a handheld microscope and a topical fluorescent imaging agent dubbed PARPi-FL. This imaging technique targets the PARP1 enzyme, which is overexpressed in this type of cancer. It has the potential to revolutionize cervical cancer biopsies and screenings. Cervical cancer is the fourth most common cancer in women. Data shows that in 2018, nearly 600,000 women were diagnosed with this cancer type globally, with roughly 310,000 of them succumbing to the disease. Almost 99% of cervical cancer cases are caused by human papilloma virus (“HPV”), which can…

WednesdayAug 11, 2021 10:29 am

Brain Fingerprints May Facilitate Neurological Disease Detection

A scientist at EPFL (the Swiss Federal Institute for Technology) has discovered that it is possible to detect declining cognitive function by using the fingerprints of an individual’s brain. Brain fingerprints refer to the neural connections’ map as detected by brain imaging techniques. The scientist stumbled upon this discovery after noticing that the brain fingerprints in individuals suffering from cognitive decline are more difficult to detect compared to how easily the brain fingerprints of healthy subjects can be detected. Just as is the case with fingers, the brain of each individual has a unique pattern that is embedded within it,…

TuesdayAug 10, 2021 12:37 pm

Scientists Can Use Blood Plasma, Urine Tests to Detect Brain Tumors

Scientists from the Cancer Research UK Cambridge Institute have designed tests that can detect the presence of a type of brain tumor known as a glioma via a patient’s blood plasma or urine. The group notes that this test is the first of its kind globally, adding that its results, which only included a handful of patients, are promising. The research is currently in its early stages and was published in “EMBO Molecular Medicine.” Brain tumor recurrence in individuals who have already had a brain tumor removed is high, which is why monitoring patients using an MRI scan is important.…

TuesdayAug 10, 2021 11:04 am

Brain Scientific Inc. (BRSF) Addresses Critical Neurologist Shortfall with Cost-Effective, Portable Brain Diagnostic Devices

American Academy of Neurology warns of critical neurologist shortfall amid increased incidence of brain disorders Brain Scientific addresses issue with portable, cost-effective brain diagnostic solutions that record EEGs in nearly any setting Product development includes creation of AI and ML algorithms to detect seizures, dementia and other brain-related conditions NeuroCap and NeuroEEG device patents approved in U.S., Europe and China With a goal of addressing the current acute neurologist shortfall in the United States (https://ibn.fm/DrxvC), Brain Scientific (OTCQB: BRSF), a commercial-stage health care company, has developed cost-effective and portable proprietary medical devices that are positioned to disrupt the electroencephalogram (“EEG”)…

MondayAug 09, 2021 1:57 pm

How to Make Remote Healthcare Better for Everyone as Implementation Spreads

Even before the coronavirus pandemic began, remote healthcare was on the rise. Remote healthcare, which is fast becoming the preferred way to deliver healthcare, has many benefits including reducing costs and freeing up healthcare facilities for critical needs. It also provides more meaningful and robust data. Many view remote healthcare as more effective and efficient at tracking the health of patients in their natural environment, with physicians noting that more accurate data leads to better outcomes. Moving standard medical visits online also offers patients more flexibility and physicians more time to prepare for a more efficient and higher value interaction…